Clinical Trials List
2022-01-01 - 2026-12-31
Phase III
Recruiting10
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/15
Investigators and Locations
Co-Principal Investigator
- Inn-Wen Chong 未分科
- 鄭孟軒 無
- 陳家閔 無
- Ming-Ju Tsai 無
- Hung-Ling Huang 未分科
- 鄭至宏 無
- 蔡毓真 無
- Chih-Jen Yang 無
- KUAN-LI WU 未分科
- jong rung Tsai 無
- Jen-Yu Hung 未分科
- 李玫萱 未分科
- Wei-An Chang 無
- Ying-Ming Tsai Tsai 無
- Hung-Ling Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林倡葦 無
- Horng-Chyuan Lin 無
- 黃鴻育 無
- Fu-Tsai Chung 無
- 羅君禹 無
- Wan-Jing Ho 無
- 萬永亮 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Yu Chen Division of Thoracic Medicine
- 蘇冠名 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HAO-CHIEN WANG Division of Thoracic Medicine
- 張允中
- 許嘉林
- Ping-Hung Kuo
- YAO-WEN KUO
- 賀立婷
- 黃俊凱
- 鄭之勛
- 錢穎群
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
41 participants
-
Global
1060 participants
